Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive
Clinical trial NCT01489046 · TERMINATED
Trial details
- NCT number
- NCT01489046
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2013-03-01
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.